Heat Biologics Secures $5,050,050 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1b6e1b6c-4383-45bf-b8b3-352742e81e4d - Date
4/10/2013 - Company Name
Heat Biologics - Mailing Address
100 Europa Drive Chapel Hill, NC 27517 USA - Company Description
Heat Biologics (Heat) is a clinical-stage company focused on the development and commercialization of its HS-System, a platform technology that offers a novel approach to treating cancer and other diseases by using live, modified cell lines to activate the immune system against specific defined targets. - Website
http://www.heatbio.com - Transaction Type
Venture Equity - Transaction Amount
$5,050,050 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
